Ujházy E, Nosál R, Zeljenková D, Balonová T, Chalupa I, Siracký J, Blasko M, Metys J
Institute of Experimental Pharmacology, Slovak Academy of Sciences, Bratislava, Czechoslovakia.
Agents Actions. 1988 Apr;23(3-4):376-8. doi: 10.1007/BF02142592.
The teratogenic and cytogenetic effects of two drugs with antihistamine properties, Pipethiadene and Pizotifen maleate, were investigated. Three groups of pregnant mice were treated daily with oral doses (0.24, 0.6 and 1.2 mg/kg) of these drugs from day 4 to day 16 of gestation. The following parameters were investigated: reproductive health of the dams, external, skeletal and visceral malformations of fetuses and frequencies of micronuclei and chromosome aberrations in bone marrow cells of dams. Oral administration of Pipethiadene or Pizotifen maleate produced no teratogenic effects. No elevation was observed in the frequencies of micronuclei and chromosome aberrations. However, the significant reduction of fetal weight after all doses of Pipethiadene or Pizotifen maleate was found to correlate well with the decreased values of the mitotic indices of bone marrow cells of mice, suggesting a potential embryotoxic effect of the tested substances.
研究了具有抗组胺特性的两种药物——哌替丁和马来酸匹莫齐特的致畸作用和细胞遗传学效应。将三组怀孕小鼠在妊娠第4天至第16天每天口服这些药物(剂量分别为0.24、0.6和1.2毫克/千克)。研究了以下参数:母鼠的生殖健康、胎儿的外部、骨骼和内脏畸形以及母鼠骨髓细胞中微核和染色体畸变的频率。口服哌替丁或马来酸匹莫齐特未产生致畸作用。微核和染色体畸变的频率未观察到升高。然而,发现所有剂量的哌替丁或马来酸匹莫齐特给药后胎儿体重显著降低,这与小鼠骨髓细胞有丝分裂指数的降低值密切相关,表明受试物质具有潜在的胚胎毒性作用。